Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
Behcet's syndrome is an autoimmune disease of the seronegative vasculitic type, with a disease of vessels of variable caliber. It is mainly characterized by oral ulcers, genital ulcers and uveitis. The purpose of this case is to describe the oral manifestations and therapeutic behavior to be followed before a patient with Behcet syndrome. For our purpose, the case of a 20-year-old patient, female, black race, urban origin, who goes to the emergency departments of Maxillofacial Surgery of the body of guard of the Provincial Hospital Dr. Gustavo Aldereguía Lima in the province of Cienfuegos, referred by the specialist in Comprehensive General Stomatology who provided services in the area of health corresponding to the patient for presenting multiple ulcerated lesions throughout the oral cavity and lips. It was concluded that oral ulcers in Behcet's disease are the first clinical manifestation, which in most cases, lead the patient to seek medical help and are considered by countless authors as the cornerstone to reach the diagnosis of this disease. A total of 14 bibliographies were consulted.
JORDI - Journal of Oral Diagnosis, 2016
Behçet's disease is a chronic multisystem inflammatory disorder of unknown etiology and characterized mainly by recurrent oral ulcers, ocular involvement, genital ulcers, and skin lesions, presenting with remissions and exacerbations. Case report: The case report presents a patient with recurrent oral ulcers history and extracutaneous ulcers to 10 years who was diagnosed as having Behçet's disease and was successfully treated. Discussion: Although complications involving the gastrointestinal, cardiovascular, renal, pulmonary, urological, artery, and central nervous system can be observed, some patients can remain asymptomatic for a long period after the diagnosis. Conclusion: This report emphasises that systemic diseases, including Behçet's disease, can have variable presentations and can be frequently misdiagnosed.
Revista Española de Cirugía Oral y Maxilofacial, 2014
International Journal of Applied Dental Sciences, 2020
Behçet’s disease (BD) is a systemic vasculitis whose main signs are: mouth ulcers, genital ulcers and uveitis. BD involves a particular immunogenetic field whose etiopathogenesis remains unknown until our days. Diagnosis of BD rests on clinical signs also the doctor’s judgment and experience since there’s no pathognomonic sign or specific test for the disease. In BD the oral manifestation which is recurrent oral aphthous is one of the major diagnostic criteria. In addition to this manifestation, ocular and neurological damages can cause serious sequelae. The management of BD is multidisciplinary. The dentist plays a key role in contributing greatly to the early diagnosis of the disease since the first and most widespread manifestation is recurrent oral aphthous. He is also responsible of the topical treatment of aphthous stomatitis or he can manage the oral consequences induced by the basic treatment of the disease.
Medical case reports and reviews, 2019
Background: Behcet syndrome is a chronic multisystem vasculitis of unknown origin with frequent manifestation of oral and genital ulcerations, ocular and skin lesions and other involvement of the central nervous system and the gastrointestinal tract. We present a case of Behcet syndrome presenting initially with isolated oral aphthous ulcers and the aim is to highlight the clinical features and its treatment. Case Report: A 36 year old female with recurrent aphthous ulcers on the tongue for 2 days with a history of frequent recurrence. Patient responded initially to topical triamcinolone acetonide and low dose prednisolone. Two weeks later, there was a recurrence of oral aphthous with erosions on the oral mucosa with skin and genitalial lesions. A diagnosis of Erythema Multiforme major was made and patient placed on higher dose steroid with resultant healing. There was another recurrence with lip crusting, sore throat, skin lesions, conjuctival inflammation and genitalia ulcerations. We made a diagnosis of Behcet's syndrome. Patient was placed on Dapsone resulting in complete resolution of the lesions with no recurrence within and after three months of several recall visits. Conclusion: A case of Behcet's syndrome that affected the oral mucosa at initially and later the conjunctiva, the skin, and the genitalia in a 36 year-old female. Health professionals should be aware of this rare condition.
Acta reumatológica portuguesa
Behçet's disease is a relapsing multisystem polysymptomatic disease with exacerbations and remissions defined by the presence of the major symptom, recurrent oral aphthous ulcers, plus two of the following: recurrent genital ulceration, eye lesions, skin lesions or a positive pathergy test. Mucocutaneous manifestations like oral and genital ulcers, and cutaneous lesions (papulopustular lesions, erythema nodosum-like lesions, cutaneous ulcers, superficial thrombophlebitis), are considered the \"fingerprint\" of the disease, being the most common and often the first signs to appear. Although the exact etiopathogenesis is still not known, genetic predispose and environmental factors may influence and contribute to the development of this disease. Diagnosis is based in the International Study Group criteria. During the last years, this disease has been largely studied and new immunological data and treatment strategies have been postulated. Despite that, further studies an...
Journal of Advances in Medical and Biomedical Research
10.30699/jambs.28.130.284 Background & Objective: Behçet's disease (BD) is a multisystemic inflammatory vascular disorder with an autoimmune background. It is a genetic disease which can be affected by environmental factors. Behçet's disease may involve different organs like urogenital system, skin, eyes, and gastrointestinal system. The prevalence of the disease varies considering the geographic area and genetic predisposition. This study aims to evaluate some clinical features of mucocutaneous lesions of BD. Materials & Methods: This cross-sectional study was done on 43 patients with BD (24 men, 19 women). Age, sex, disease duration, and history of receiving medication were investigated. The self-reported questionnaire was completed by participants. Skin manifestations and genital and ocular involvements were also documented. Results: Male to female ratio was measured 1.26:1. Oral aphthous commonly localized on the lips. Ocular involvements and skin lesions prevalence percentages were 76% and 48%, respectively. There was a statically significant correlation between ocular lesions and age. Skin lesions and the frequency of oral aphthous per year had a significant relationship. There also was a significant relationship between the incidence of ocular lesions and skin lesions. Conclusion: Oral aphthous, the most popular manifestation of BD, is the hallmark of diagnosis. Thus, patients with oral aphthous require close surveillance for other manifestations of BD for timely diagnosis and reference to a rheumatologist.
Revista Española de Cirugía Oral y Maxilofacial, 2015
a b s t r a c t Behç et's disease (BD) is a multi-systemic vascular disorder characterized by oral and genital ulcers, as well as cutaneous, ocular, arthritic, vascular, central nervous system and gastrointestinal involvement. It usually affects young adults, and its pathological origin is unknown. The case of a 47-year-old woman with recurrent ulcers in the oral cavity is presented. She linked the pain with sitting and during the sexual act, with vaginal and oral cavity pain, due to the lesions present at those sites, as well as swelling and pain in the knees, making walk painful. The patient was kept under observation and underwent multidisciplinary treatment with prescription of topical and systemic drugs to improve quality of life. Dentists should be aware of BD and the need of multidisciplinary treatment to increase the patient's quality of life.
Clinical, Cosmetic and Investigational Dermatology
Background: Behçet's disease is a potentially fatal vasculitis disorder involving vessels in both the arterial and venous systems. Cutaneous manifestation is the most common sign in Behçet's disease, but its relation to disease activity and prognosis is lacking. Objective: Our study aims to determine the relationship between cutaneous, extracutaneous manifestations with Behçet's disease activity, morbidity, and mortality. Materials and Methods: Patients diagnosed with Behçet's disease were identified by using the 1990 International Study Group for Behçet's disease criteria and/or the 2014 international criteria for Behçet's disease. Data regarding patients' clinical manifestations, laboratory results, disease activity, and prognosis were retrieved and analyzed. Disease activity was evaluated using the 2006 Behçet's disease current activity form (BDCAF). Results: Of 119 patients, the mean age at diagnosis was 35.7 ± 10.7 years and 60% were female. Median disease duration was 96 months (IQR 48-168). Minor oral ulcer at the buccal mucosa was associated with lower median BDCAF score (p = 0.003), whereas minor oral ulcer at the tonsil was related to higher BDCAF score (p = 0.024). Male gender was associated with higher cumulative dose of corticosteroids (p = 0.003) and hospitalization (OR = 2.89 (95% CI [1.10, 7.57]), p = 0.031). Ocular manifestations were related to higher dose of corticosteroids (p = 0.002) and morbidity (OR = 4.39 (95% CI [1.57, 12.29]), p = 0.005). Conclusion: Our study suggests that different locations of minor oral ulcers help predict disease activity. Male gender and the presence of ocular manifestations resulted in less favorable outcomes for Behçet's disease.
Clinical Rheumatology, 2014
The clinical course of Behcet's disease (BD) as a multisystemic disorder with a remitting-relapsing nature is insufficiently explored. As complete remission should be aimed in all inflammatory diseases, we investigated the frequency of complete remission in patients with BD followed in long-term, routine practice. In this retrospective study, 258 patients with BD who were regularly followed in outpatient clinics were assessed. The demographic and clinical data for active organ manifestations and treatment protocols were evaluated, and "complete remission" for this study was defined as no sign of any disease manifestation in the current visit and the preceding month. Two hundred fifty-eight patients with BD (F/M 130/128, mean age 41.1±11.5 years) were included to the study. Mucocutaneous disease was present in 48.4 % (n=125). Mean visit number was 6.8±2.7, and mean follow-up duration was 45.8±36.5 months. Patients were clinically active in 67.2 % (n=1,182) of the total visits (n=1,757), which increased to 75.6 % (68.1-90.3) when the month preceding the visit was also included. The most common active manifestation was oral ulcers (39.4-63.2 %) followed by other mucocutaneous manifestations and musculoskeletal involvement. When multivariate analysis was performed, oral ulcers, which are the main cause of the clinical activity, negatively correlated with immunosuppressive treatments (β=−0.356, p<0.000) and age (β=−0.183, p=0.04). It is fairly difficult to achieve complete remission in BD with current therapeutic regimens. The reluctance of the clinician to be aggressive for some BD manifestations with low morbidity, such as mucocutaneous lesions and arthritis, might be influencing the continuous, low-disease activity state, especially due to oral ulcers, in BD patients.
Clinical and experimental rheumatology
The numbers and recurrence rates of mucocutaneous manifestations can be highly variable among patients with Behçet's syndrome (BS) but it is not known whether these differences influence the disease course at the long-term. We evaluated the outcome of 30 patients that made up the placebo arm of a 6 months controlled trial of thalidomide and looked at the relation between the frequencies of mucocutaneous manifestations during the trial and the development of major organ involvement necessitating immunosuppressives during the post-trial period. Fifteen (50%) patients had received immunosuppresives for major organ involvement during the post-trial period. Patients receiving immunosuppressive treatment were significantly younger at the onset of BS compared to those who did not (24.5±5 vs. 29.7±3.8 SD years; p=0.003). The mean number of oral ulcers recorded throughout the trial was significantly higher among patients using immunosuppressives compared to those who did not (2.09±0.96 v...
Revue Internationale de Philosophie, vol. 70 No 277, 2016
DLA-ABIDS:Deep Learning Approach for Anomaly Based Intrusion Detection System, 2023
Anuario de Historia de la Iglesia, 2017
The New Jewish Canon, 2020
2011
Legume Research- An International Journal, Volume 47 Issue 3: 343-351 (March), 2024
American Journal of Physical Anthropology, 2007
Journal of reproduction & infertility
Journal of Mathematical Physics, 1994
Alexandria Engineering Journal, 2015
Acta Universitatis Lodziensis. Folia Litteraria Polonica, 2016
Resonance, 2005
EClinicalMedicine, 2020
Journal of Vascular and Interventional Radiology, 2016
Revista Brasileira de Gestão e Desenvolvimento Regional, 2018